SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-033161
Filing Date
2022-10-06
Accepted
2022-10-06 16:20:58
Documents
1
Period of Report
2022-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 16659
  Complete submission text file 0000899243-22-033161.txt   18155
Mailing Address BAIN CAPITAL, LLC 200 CLARENDON STREET BOSTON MA 02116
Business Address
PATRICK DEVAL L (Reporting) CIK: 0001053466 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 221298404
SIC: 4512 Air Transportation, Scheduled

Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations